Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

NCT07388277 is registered in ClinicalTrials.gov with Marcela V. Maus, M.D.,Ph.D. as lead sponsor.

NCT NCT07388277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07388277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Lead sponsor
Marcela V. Maus, M.D.,Ph.D.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
March 30, 2026
Completion date
December 31, 2029
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antineutrophil cytoplasmic antibody-associated vasculitis